MLB All-Star Alex Bregman joins Patrick Mahomes, Breanna Stewart as Throne SPORT COFFEE partner

Alex Bregman has invested in and partnered with Throne SPORT COFFEE ahead of MLB Opening Day; the brand already lists high-profile partners Patrick Mahomes and Breanna Stewart. The product touts 150mg natural caffeine, NSF Certified for Sport, 10g protein and 100% daily value of B vitamins — positioning it as a performance-oriented coffee for athletes. Bregman, who signed a five-year, $175M deal with the Cubs, plans to promote the product within a large Chicago market and among teammates during the 162-game season.

Analysis

Athlete-led endorsements materially shorten the adoption curve for premium functional beverages because they convert a high-credibility, hard-to-reach cohort (team trainers, collegiate programs, sports media) into trial customers. That demand can translate into faster retailer listings: once a product is accepted in team clubhouses and stadiums, national distributors use that credential to negotiate shelf tests with regional grocers and c-stores within 3–9 months. For incumbents this matters less as headline volume and more as a wedge for premium SKU placement and pricing power in the morning/daytime daypart, where single-serve and RTD coffee margins exceed syruped energy drinks by mid-single to low-double digits at scale.

Second-order supply effects are non-trivial: higher protein and certification requirements increase ingredient and manufacturing complexity, which raises COGS and creates scale-dependent margin profiles. Small brands that secure NSF certification and co-packing capacity can command 20–30% higher retail prices, but until co-packing is locked, gross margins will be volatile. Retail shelf crowding means incumbents with broad distribution and RTD capabilities (large CPGs, Keurig partners, major quick-serve chains) are positioned to monetize premiumization faster than pure-play startups unless the startup achieves rapid regional penetration.

Main near-term catalysts are (1) regional retail listings and c-store rollouts, (2) stadium/clubhouse distribution deals, and (3) next funding or wholesale distribution announcements — each observable within 3–12 months. Tail risks include category ceiling (premium functional coffee remains niche), protein/ingredient cost spikes, or regulatory scrutiny of supplement claims; any of these could compress multiples and reverse wholesale demand quickly. The consensus underweights the B2B-to-retail pathway: athlete credibility is a conversion accelerator, not an endpoint, so the real value to acquirers or distributors is visibility that reduces effective CAC and shelf-testing time by estimated 30–50%.

Key Decisions for Investors

• Long KDP (Keurig Dr Pepper) 3–9 month call spread to play accelerated RTD and single-serve premiumization: buy an in-the-money-to-ATM vertical to cap cost while capturing a 10–25% upside in KDP if multiple regional listings roll out. Risk: limited premium appreciation if small brands fail to secure national distribution; reward: captures distribution monetization without outright equity exposure.
• Pair trade — Long PEP (PepsiCo) vs Short MNST (Monster Beverage) over 6–12 months: expect PEP to outperform as it leverages distribution and co-branding for RTD coffee, while MNST faces incremental share pressure in daytime/health-conscious segments. Position size: 0.5–1% NAV each leg; target relative outperformance 6–12% with stop-loss at 6% adverse move in either leg.
• Buy SBUX 6–12 month call spread to hedge bullish coffee premiumization thesis in foodservice and morning dayparts: limited-cost vertical to capture re-pricing power from premium functional offerings moving consumers away from syruped alternatives. Rationale: Starbucks can convert premium trends at scale; risk is slower-than-expected category migration that leaves spreads to expire worthless.
• Small private allocation (opportunistic, 0.1–0.25% AUM) to early-stage functional beverage rounds or secondaries if available within 6–18 months: high downside volatility but asymmetric upside if brand converts athlete credibility into national distribution. Exit triggers: acquisition by large CPG or 2x revenue multiple expansion on successful national rollouts.